Psychedelics – News and Features

News
Ketamine’s Antidepressant Action Extended for the First Time
Researchers show that it is feasible to substantially extend the antidepressant action of a single dose of ketamine from its current duration of up to a week to a longer period of up to two months.

News
Stabilized, Not Shut Down: What Ketamine Really Does to the Brain
Research reveals that ketamine stabilizes brain activity in a dose-dependent way. The study used high-density EEG to track changes in brain stability, suggesting ketamine’s effects on brain dynamics might be central to its therapeutic use.

News
Psychedelic Ceremonies May Have Created Class Hierarchies in the Andes
A team of archaeologists discovered ancient snuff tubes carved from hollow bones at the heart of monumental stone structures at Chavín de Huántar, a prehistoric ceremonial site in the mountains of Peru.

News
Psilocybin Improves Mood and Motor Function in Parkinson's Patients
In a pilot study testing psilocybin therapy in Parkinson's patients, the participants experienced clinically significant improvements in mood, cognition and motor function that lasted for weeks after the drug was out of their systems.

News
MDMA and Psilocybin May Reversibly Impact Fear and Stress Responses
Mass General Brigham researchers found that immune cells influence brain communication in response to stress, driving fear behaviors. Psychedelic treatments like MDMA and psilocybin reduced fear in preclinical models and human tissue.

News
A Single Dose of Psychedelics Boosts Learning Ability for Weeks
A new study from the University of Michigan reveals that psychedelic compounds can improve cognitive flexibility in mice, with benefits lasting for weeks. The findings suggest potential treatments for psychiatric conditions like depression and PTSD.

News
Psilocybin Use Is on the Rise in the US
Use of psilocybin, the hallucinogenic chemical found in what is known as “magic mushrooms,” has increased significantly nationwide since 2019, according to a new study.

News
Scientists Redesign LSD To Create a Non-Hallucinogenic Antidepressant
UC Davis researchers developed JRT, a modified version of LSD that promotes neuroplasticity without hallucinogenic effects. Tested in mice, JRT enhanced brain connectivity, showed antidepressant effects and improved cognition.

News
Psilocybin’s Therapeutic Effects Linked to Specific Brain Pathways
Cornell researchers found that psilocybin’s therapeutic benefits depend on the pyramidal tract neurons and the serotonin 5-HT2A receptor in the medial frontal cortex. Targeting these mechanisms could allow psilocybin to treat depression.

News
Psychedelics’ Influence on Gender Identity and Sexual Experiences
A study found that psychedelic experiences enhanced relationship quality, sexual attraction and intimacy. Participants reported both short- and long-term benefits, with some experiencing changes in gender identity.
Advertisement